Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A busy month for Enzyre
June 2019
SHARING OPTIONS:

NIJMEGEN, Netherlands—Enzyre recently added to its executive management with the appointment of Dirk Polley as CEO, and also got a financial boost, having been awarded a €2-million European Fund for Regional Development (EFRO) grant in addition to closing a seed funding round. Enzyre plans to use the funding to further develop its Hemophilia Biochip technology and advance a first product to market. The platform uses a small volume of blood to measure up to 12 reactions simultaneously, for sensitive and specific testing that can be done at home or in a critical care setting.
 
Tolleiv Trimborn, chairman of Enzyre’s Supervisory Board, said: “We are delighted to have Dirk Pollet join the team as CEO. He brings a successful track record and 20 years of experience in the successful development and commercialization of in-vitro diagnostics and deal-making. We would also like to thank Guido Maertens for his commitment and hard work as founding CEO, and we are fully convinced that he will continue to contribute to the success of Enzyre as he embraces his new task as CFO.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.